Evidence map›Paper›PMID 35418688›Full record

ReviewNature protocols2022

Subretinal injection in mice to study retinal physiology and disease.

Peirong Huang, Siddharth Narendran, Felipe Pereira, Shinichi Fukuda, Yosuke Nagasaka, Ivana Apicella, Praveen Yerramothu, Kenneth M Marion, Xiaoyu Cai, Srinivas R Sadda and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in Nature protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 5 countries.

Peirong HuangCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Siddharth NarendranCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Felipe PereiraCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Shinichi FukudaCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Yosuke NagasakaCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Ivana ApicellaCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Praveen YerramothuCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Kenneth M MarionDoheny Eye Institute, Los Angeles, CA, USA.
Xiaoyu CaiCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Srinivas R SaddaDoheny Eye Institute, Los Angeles, CA, USA.
Bradley D GelfandCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Jayakrishna AmbatiCenter for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA. ja9qr@virginia.edu.
University of Virginia · USDoheny Eye Institute · US

Funding

Visual system and cognitive biology in normal animals versus in an animal model of Alzheimer's disease with or without diabetes treated with solo or dual inflammasome inhibitorsR01EY031039 · NEI · UNIVERSITY OF VIRGINIA · PI AMBATI, JAYAKRISHNA, GELFAND, BRADLEY DAVID · 2020 to 2024
$3.2M
Non-canonical inflammasome in activation in RPE degenerationR01EY029799 · NEI · UNIVERSITY OF VIRGINIA · PI AMBATI, JAYAKRISHNA · 2019 to 2022
$2.7M
Mechanistic basis of sexual dimorphism in antigen-independent IgG1 angiogenesis regulationR01HL164592 · NHLBI · UNIVERSITY OF VIRGINIA · PI Bradley David Gelfand · 2023 to 2026
$2.7M
Antigen-independent suppression of ocular angiogenesis via the Fc receptorR01EY028027 · NEI · UNIVERSITY OF VIRGINIA · PI AMBATI, JAYAKRISHNA, GELFAND, BRADLEY DAVID · 2018 to 2022
$2.2M
DICER1 deficiency in aberrant chorioretinal neovascularization - Administrative Supplement OKT RequestR01EY032512 · NEI · UNIVERSITY OF VIRGINIA · PI GELFAND, BRADLEY DAVID · 2021 to 2024
$2.1M
NEI NIH HHS R01 EY028027NEI NIH HHS R01 EY029799NEI NIH HHS R01 EY031039NEI NIH HHS R01 EY032512NHLBI NIH HHS R01 HL164592
6 · The paper itself

Abstract

Subretinal injection (SRI) is a widely used technique in retinal research and can be used to deliver nucleic acids, small molecules, macromolecules, viruses, cells or biomaterials such as nanobeads. Here we describe how to undertake SRI of mice. This protocol was adapted from a technique initially described for larger animals. Although SRI is a common procedure in eye research laboratories, there is no published guidance on the best practices for determining what constitutes a 'successful' SRI. Optimal injections are required for reproducibility of the procedure and, when carried out suboptimally, can lead to erroneous conclusions. To address this issue, we propose a standardized protocol for SRI with 'procedure success' defined by follow-up examination of the retina and the retinal pigmented epithelium rather than solely via intraoperative endpoints. This protocol takes 7-14 d to complete, depending on the reagent delivered. We have found, by instituting a standardized training program, that trained ophthalmologists achieve reliable proficiency in this technique after ~350 practice injections. This technique can be used to gain insights into retinal physiology and disease pathogenesis and to test the efficacy of experimental compounds in the retina or retinal pigmented epithelium.

Indexed as

RetinaRetinal Pigment EpitheliumAnimalsInjectionsMiceReproducibility of Results

Identifiers

PMID35418688
PMCPMC11146522
OpenAlexW4224136669

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.